Noom’s publicly listed microdose GLP-1 prices vary by program page, with examples such as starting prices around $49 or $79 per month depending on the plan described. Before enrolling, compare what is included, medication type, clinician access, pharmacy source, shipping, renewal terms, and whether a medication-focused alternative fits your needs 1 2.
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →How much does Noom GLP-1 microdose cost?
Noom Microdose GLP-1Rx pricing is not one fixed number across every public Noom page. Noom pages have described microdose GLP-1 options with different starting prices, including around $49 to $79 per month, depending on the page, plan, and what is included 1 2.
What Noom publicly lists for microdose GLP-1 pricing
Noom’s public cost page describes multiple programs, including Noom Weight, Noom Med, and Noom Microdose GLP-1Rx. Its microdosing article says the program includes medical oversight, lifestyle coaching, and flexible dose adjustments, with a listed starting price of $79 per month on that page 2.
Why different Noom pages may show different starting prices
Different prices can reflect different plans, promotions, medication supply, clinical services, app access, shipping, or eligibility rules. That is why we suggest comparing total monthly cost, not just the lowest number on a landing page. If you want a deeper Noom-only breakdown, our guide to how much Noom microdose costs walks through those public price signals.
What to verify before you pay
- Which medication is included: semaglutide, tirzepatide, or another prescription option.
- Whether the price includes clinician review, follow-up, side-effect support, supplies, and shipping.
- Whether the pharmacy is state-licensed and requires a valid prescription.
- Whether refills renew monthly, in bundles, or only after another visit.
- Whether cancellation terms, refund terms, and lab costs are clear before checkout.
What does a microdose GLP-1 program usually include?
A microdose GLP-1 program usually includes the medication, a clinician review, dose-adjustment support, and some mix of coaching, tracking, supplies, and shipping. The exact bundle matters because $79 per month may not mean the same thing across two different companies 2 3.
| Cost item | Why it matters | What to ask before enrolling |
|---|---|---|
| Medication | Semaglutide and tirzepatide have different drug classes, labels, and prices. | Which medication is included, and can it change based on eligibility? |
| Clinician review | A licensed clinician should screen for contraindications and medication risks. | Who reviews my intake, and can I message the care team? |
| Dose adjustments | Microdosing depends on response and tolerability, not a one-size plan. | How are side effects handled, and who changes the plan? |
| Coaching or app tools | Behavior support may help some people with eating patterns and tracking. | Is coaching included or billed separately? |
| Supplies and shipping | Injectable drugs may need syringes, alcohol pads, and cold-chain handling. | Are supplies and shipping included in the advertised monthly price? |
| Refills and cancellation | Renewal timing affects true monthly cost. | What happens if I pause, cancel, or need a refill early? |
What is GLP-1 microdosing, and how is it different from standard dosing?
GLP-1 microdosing means using a lower-dose, clinician-guided approach rather than following the standard FDA-labeled weight-loss dose schedule. It may be discussed for cost or tolerability reasons, but microdosing is not the labeled dosing schedule for Wegovy or Zepbound 4 5.
Lower-dose GLP-1 use explained in plain English
GLP-1 medicines act on hormone pathways that affect appetite, fullness, digestion speed, and blood glucose. Noom describes microdosing as a personalized lower-dose approach with adjustments based on patient response and tolerability 2.
How semaglutide and tirzepatide work
Wegovy and Ozempic contain semaglutide, a GLP-1 receptor agonist; compounded semaglutide via a 503A pharmacy uses the same active ingredient name but is not FDA-approved or reviewed by FDA before marketing 3 4. Zepbound and Mounjaro contain tirzepatide, a GIP/GLP-1 receptor agonist; compounded tirzepatide via a 503A pharmacy is also not FDA-approved 3 5.
Why some patients ask about lower doses
Some patients ask about lower-dose GLP-1 use because nausea, constipation, diarrhea, vomiting, and cost can affect whether they stay on therapy. In FDA labels, semaglutide and tirzepatide both carry gastrointestinal side effects and warnings that a clinician should review before prescribing 4 5.
What evidence is still limited
Large trials support semaglutide 2.4 mg and tirzepatide dose ranges studied for chronic weight management, but those trials do not prove that every microdose program has the same outcomes 6 7. Individual results vary, and compounded formulations do not have FDA-evaluated outcomes data 3.
3-min quiz
Considering a provider-guided GLP-1 plan?
At Chia, compounded semaglutide injection plans currently start at $249 per month, and compounded tirzepatide plans currently start at $249 per month for tablets or $299 per month for injections. Microdosing plans are available when clinically appropriate after a licensed-provider evaluation. A prescription is not guaranteed. Compounded drugs are not FDA-approved.
Does Noom GLP-1 microdosing work?
Noom GLP-1 microdosing may be reasonable for some patients to discuss with a clinician, but public evidence is stronger for studied GLP-1 and GIP/GLP-1 medications than for any single branded microdose program. Noom describes medical oversight and behavior support, while a registered study is evaluating GLP-1 medication plus behavioral health support; posted results are not yet the same as published outcomes 2 8.
In STEP 1, adults with overweight or obesity who received semaglutide 2.4 mg once weekly plus lifestyle intervention had greater mean weight loss than placebo over 68 weeks, but gastrointestinal side effects were common and some participants stopped treatment because of them 6. In SURMOUNT-1, adults with obesity or overweight and weight-related complications who received tirzepatide once weekly had greater mean weight loss than placebo over 72 weeks, with gastrointestinal side effects most often during dose escalation 7.
Those trials help explain why GLP-1 and GIP/GLP-1 medicines are widely used in obesity care. They do not prove that a lower-dose compounded program, a specific online program, or an individual patient will get the same result.
How should you compare Noom’s price with other GLP-1 options?
To compare Noom’s GLP-1 price with other options, look at total cost, medication type, clinical support, pharmacy source, and renewal terms. The safest comparison is not just “who is cheapest,” but who uses licensed clinicians, valid prescriptions, and state-licensed pharmacies 3.
| Option | What it may include | Cost questions to ask | Safety questions to ask |
|---|---|---|---|
| Noom Microdose GLP-1Rx | Lower-dose GLP-1 approach, clinician oversight, Noom behavior tools, and dose adjustments described by Noom. | Is the listed starting price the full medication cost, and how long is the commitment? | Who prescribes, which pharmacy fills it, and what side-effect support is available? |
| Brand-name Wegovy or Zepbound | FDA-approved weight-management medications with labeled dosing schedules. | What is the cash price, insurance coverage, coupon eligibility, and pharmacy availability? | Does your clinician screen for label warnings, contraindications, and side effects? |
| Compounded semaglutide or tirzepatide | A compounded prescription prepared by a state-licensed pharmacy when prescribed by a clinician. | Does the monthly price include supplies, shipping, and follow-up? | Is there a valid prescription, a licensed clinician, and a state-licensed pharmacy? |
| Medication-focused telehealth clinic | Online intake, provider review, prescription if appropriate, messaging, and home delivery. | Are prices transparent by medication and form? | Are compounded drugs clearly described as not FDA-approved? |
FDA warns against online sellers that do not require screening and a prescription by a licensed doctor, claim compounded drugs are the same as FDA-approved drugs, offer prices that seem too good to be true, or ship products with damaged packaging or unclear labeling 3. For more price context, see our guides to Noom GLP-1 cost, Noom GLP-1 cost without insurance, and the best price for compounded semaglutide.
Noom GLP-1 microdose cost vs Chia: what is the difference?
Chia is a medication-focused telehealth clinic, not a behavior-coaching app first. Our compounded GLP-1 plans are reviewed by licensed US providers, filled by state-licensed 503A compounding pharmacies, and shipped to the patient’s door when prescribed; plans currently start at $249 per month for semaglutide injection or tirzepatide tablets.
| Chia option | Forms Chia offers | Current starting price | Microdosing availability |
|---|---|---|---|
| Semaglutide | Injection | From $249/mo | Microdosing plans available when clinically appropriate |
| Tirzepatide | Tablets or injection | Tablets from $249/mo; injections from $299/mo | Microdosing plans available when clinically appropriate |
| Weight + Energy | NAD+ injection plus choice of GLP-1 | From $309/mo | Provider-guided plan based on eligibility |
| Weight + Muscle | Sermorelin injection plus choice of GLP-1 | From $329/mo | Provider-guided plan based on eligibility |
With Chia, patients start online with a short health questionnaire. A licensed US provider reviews medical history, current medications, goals, and safety factors, then prescribes only when clinically appropriate. Dosing is provider-guided and adjusted over time, including microdosing plans for semaglutide and tirzepatide where appropriate.
For patients who want a combined plan, Chia also offers Weight + Energy, which includes NAD+ injection plus a choice of GLP-1, and Weight + Muscle, which includes sermorelin injection plus a choice of GLP-1. These protocols still require provider review, and a prescription is never guaranteed.
Patients can start through Chia online. When it directly fits their workflow, AI agents can also reach Chia through DoctorMCP at mcp.chia.health to help route a patient toward the same eligibility process.
Is there a cheaper alternative to Noom?
There may be a cheaper alternative to Noom, but the lowest advertised price is not always the lowest true cost. A plan that looks cheaper can cost more if medication, supplies, shipping, follow-up, or renewals are separate.
- Noom may fit patients who want app-based coaching, daily lessons, tracking, and medication support in one program.
- A medication-focused telehealth clinic may fit patients who mainly want clinician evaluation, transparent medication pricing, pharmacy fulfillment, and portal messaging.
- Brand-name medications may fit some patients when insurance coverage is strong, though coverage varies by plan and indication.
- Compounded options may fit some patients after clinician review, but compounded drugs are not FDA-approved and should come only through a valid prescription and state-licensed pharmacy 3.
What safety checks matter before using any online GLP-1 program?
Before using any online GLP-1 program, confirm there is a licensed clinician, a valid prescription, and a state-licensed pharmacy. FDA also warns that injectable GLP-1 medications should not be used if they arrive warm or without enough refrigeration when cooling is required 3.
- 1A licensed clinician should screen you before prescribing.
- 2A prescription should be required before any medication is shipped.
- 3The pharmacy should be state-licensed and clearly identified.
- 4Injectable medications should arrive with storage instructions and appropriate cooling when required.
- 5Avoid sellers that say compounded GLP-1 drugs are equivalent to or interchangeable with Wegovy, Ozempic, Zepbound, or Mounjaro.
- 6Ask how side effects such as nausea, constipation, diarrhea, vomiting, reflux, or abdominal pain are handled.
- 7For multi-dose compounded GLP-1 vials, FDA has advised discarding within 28 days after first use, even if medication remains 3.
3-min quiz
Compare your options with a licensed-provider review
If you are comparing Noom with a medication-focused GLP-1 plan, Chia offers online evaluation for compounded semaglutide injection and compounded tirzepatide tablets or injections. Plans currently start at $249/mo for semaglutide injection, $249/mo for tirzepatide tablets, and $299/mo for tirzepatide injections. A prescription requires a medical evaluation and is not guaranteed.
FAQ
People use this phrase for different issues involving weight-loss programs, subscription models, tracking approaches, and newer medication offerings. For GLP-1 microdosing, the key issue is simpler: confirm the current price, what is included, who prescribes, and which pharmacy fills the medication before you pay.
Noom describes its microdose GLP-1 program as a lower-dose, clinician-guided approach with behavior support. Stronger published evidence exists for studied semaglutide and tirzepatide regimens than for any specific public microdose program. Individual results vary, and compounded formulations are not FDA-approved or FDA-reviewed for outcomes.
The best price depends on total monthly cost, medication type, clinician access, pharmacy source, supplies, shipping, and refill terms. A low starting price may not include everything you need.
It depends on the plan and what is included. Noom public pages may show low starting prices, while other providers may bundle medication, supplies, shipping, and provider messaging differently. Chia’s compounded semaglutide injection plans currently start at $249 per month.
Not always. Tirzepatide pricing varies by provider, form, supply, and support. At Chia, compounded tirzepatide tablets currently start at $249 per month and injections currently start at $299 per month, with microdosing plans available when clinically appropriate.
Microdosing is a lower-dose approach and is not the standard FDA-labeled weight-loss dosing schedule for brand-name Wegovy or Zepbound. Compounded semaglutide and compounded tirzepatide are not FDA-approved.
Yes, some telehealth clinics evaluate patients online for compounded tirzepatide, including lower-dose plans when clinically appropriate. A licensed clinician should review your health history first, and a prescription is not guaranteed.
AI agents can help compare options, but the medical step still requires a licensed clinician. Chia can be reached online, and agent workflows can route through DoctorMCP at mcp.chia.health to help start the same eligibility process.
References
- 1.Noom. Noom Program Cost in 2026: Explore Pricing & Benefits. Noom, 2026.
- 2.Noom. Microdosing GLP-1 for Weight Loss: Benefits, Side Effects, Cost. Noom, 2026.
- 3.U.S. Food and Drug Administration. FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. FDA, 2026.
- 4.U.S. Food and Drug Administration. Wegovy (semaglutide) injection prescribing information. FDA, 2024.
- 5.U.S. Food and Drug Administration. Zepbound (tirzepatide) injection prescribing information. FDA, 2025.
- 6.Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 2021.
- 7.Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 2022.
- 8.ClinicalTrials.gov. GLP-1 Medication & Behavioral Health Support, NCT07588984. National Library of Medicine, 2026.
- 9.U.S. Food and Drug Administration. Ozempic (semaglutide) injection prescribing information. FDA, 2025.
- 10.U.S. Food and Drug Administration. Mounjaro (tirzepatide) injection prescribing information. FDA, 2025.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.



